|Mr. Marcos Agramont||CEO & Director||N/A||N/A||N/A|
|Mr. Eli Dusenbury||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Patrick Edward Ogle J.D., L.L.M.||COO & Director||N/A||N/A||N/A|
|Mr. Marvin Washington||VP of Bus. Devel. & Director||N/A||N/A||N/A|
|Mr. Soheil Samimi||Advisor||N/A||N/A||N/A|
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer products and solutions in Canada, Latin America, Asia, and Europe. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; and producing bioactive cannabinoids that are used in pharmaceutical applications, including life-threatening and non-life-threatening illnesses, as well as the provision of apparel and merchandising solutions. The company is headquartered in Vancouver, Canada.
Isodiol International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.